- What is the question being addressed? Is it of strategic relevance to cystic fibrosis?
- Quality of the lead PI in cystic fibrosis research and in managing multi-investigator led research programmes.
- Scientific excellence of the team. Is this the best team that could be assembled? What are the training opportunities for the young career scientists employed on the grant?
- What are the likely outcomes and how will these benefit patients with cystic fibrosis?
Additional factors that will be considered are: planning for longer term sustainability following the end of the grant, and whether the SRC brings additional (non-Cystic Fibrosis Trust funded) resources to the centre.
As detailed in our research strategy, funding by the Trust for research needs to demonstrate attention to the SCORE principles.
- Strategic: demonstrate exceptional relevance to one or more strategic priority.
- Collaborative: demonstrate the clear added-value of bringing a group of researchers together to tackle a major concern in cystic fibrosis.
- Outcome-focused: demonstrate a clear understanding of the potential impact of the programme of work on cystic fibrosis outcomes.
- Risk-based: we plan to manage a balanced research portfolio of varying risks: high risk vs lower risk and basic vs applied sciences.
- Excellence-driven: scientifically excellent and conducted by an internationally leading research team